To determine the contribution of CNVs in OA/TOF aetiology, we profiled 375 Dutch, German and American OA/TOF patients in a comprehensive multiplatform array. We suggest that genomic de novo and rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results